OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Transmission patterns of hepatitis E virus	177
Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines	139
Editorial overview: The virome in health and disease (2022)	106
Editorial Board	79
Editorial Board	79
Editorial Board	76
Editorial Board	71
Editorial Board	63
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	62
Editorial Board	62
Editorial overview: Engineering elimination of chronic viral hepatitis	61
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	61
Inhaled aerosol viral-vectored vaccines against tuberculosis	60
Cryo-electron microscopy of nodavirus RNA replication organelles illuminates positive-strand RNA virus genome replication	59
Seeing and touching adenovirus: complementary approaches for understanding assembly and disassembly of a complex virion	58
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	55
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	52
Alohomora! What the entry mechanisms tell us about the evolution and diversification of giant viruses and their hosts	51
The morphogenesis of different giant viruses as additional evidence for a common origin of Nucleocytoviricota	45
Editorial overview: Special issue on antiviral strategies in Current Opinion in Virology	44
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	43
Unresolved questions in the zoonotic transmission of MERS	42
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	42
Gradual adaptation of animal influenza A viruses to human-type sialic acid receptors	42
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	41

Host cell-intrinsic innate immune recognition of SARS-CoV-2	38
Structural insights into hepatitis C virus neutralization	37
Role of trained innate immunity against mucosal cancer	36
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	36
Retasking of canonical antiviral factors into proviral effectors	35
Tissue-resident memory T cells in protective immunity to influenza virus	34
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success	34
Asymmetry in icosahedral viruses	33
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	33
When good turns bad: how viruses exploit innate immunity factors	33
Immune–bacteriophage interactions in inflammatory bowel diseases	32
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	30
Host–pathogen interactions of emerging zoonotic viruses: bats, humans and filoviruses	30
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses	29
Plant negative-stranded RNA virus biology and host interactions revitalized by reverse genetics	28
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	27
The enigmatic roles of Anelloviridae and Redondoviridae in humans	27
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	27
Hepatitis B virus–host interactions and novel targets for viral cure	26
The influence of microbiota-derived metabolites on viral infections	26
Antivirals targeting paramyxovirus membrane fusion	25
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals	25
Quantitative measures of within-host viral genetic diversity	24
Current challenges to virus discovery by meta-transcriptomics	24
Future considerations for the mRNA-lipid nanoparticle vaccine platform	24
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	24
A structural view of the SARS-CoV-2 virus and its assembly	23
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	23
Editorial Board	22
Non-structural protein 5 (NS5) as a target for antiviral development against established and emergent flaviviruses	22
Virus-host interactions during tick-borne bunyavirus infection	21
Editorial overview: Viral pathogenesis	21
Editorial overview: Virus structure and expression	21
Editorial overview: Special issue on virus structure and expression in current opinion in virology	21
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	21
Barriers to hepatitis C virus infection in mice	21
Assembly of the virome in newborn human infants	20
Editorial overview: Viruses and Cancer	20
Oncogenic Animal Herpesviruses	20
Immune responses to human respiratory coronaviruses infection in mouse models	19
Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1	19
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	19
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	19
UPR signaling at the nexus of plant viral, bacterial, and fungal defenses	18
The gut virome in inflammatory bowel diseases	18
Structural basis for respiratory syncytial virus and human metapneumovirus neutralization	18
Editorial overview: The lung, the gut, and the genital mucosae: microbial targets and therapeutic playgrounds	18
The virome of vector mosquitoes	18
Virus–host protein interactions as footprints of human cytomegalovirus replication	18
Immunotherapy for KSHV-associated diseases	17

Modeling zoonotic and vector-borne viruses	17
Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine	17
Structural basis for neutralization of enterovirus	17
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	17
The intestinal virome: lessons from animal models	16
Natural killer cells and unconventional T cells in COVID-19	16
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets	16
Fishing for phages in metagenomes: what do we catch, what do we miss?	16
T cell responses during HBV and HCV infections: similar but not quite the same?	16
Proteases and variants: context matters for SARS-CoV-2 entry assays	16
Fighting viruses with computers, right now	15
Human brain tissue cultures: a unique ex vivo model to unravel the pathogenesis of neurotropic arboviruses	15
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	15
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	15
Human placental models for studying viral infections	15
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	14
Role of the intestinal microbiota in host defense against respiratory viral infections	14
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	14
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	14
Mechanisms of HCV resistance to broadly neutralizing antibodies	14
Global overview and major challenges of host prediction methods for uncultivated phages	13
Advances in human monoclonal antibody therapy for HBV infection	13
Editorial Board	13
Structural perspectives on HCV humoral immune evasion mechanisms	13
Virus genomics: what is being overlooked?	13
Deimmunization of flagellin adjuvant for clinical application	13
Editorial Board	13
SARS-CoV-2 vaccines — the biggest medical research project of the 21st century	12
Editorial overview: Mechanisms in the molecular interactions of plants with viruses and viroids	12
Antigenic evolution of SARS coronavirus 2	12
Editorial Board	12
Digital phagograms: predicting phage infectivity through a multilayer machine learning approach	12
Editorial Board	12
Phage therapy for secondary bacterial infections with COVID-19	11
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	11
The interplay between capsid dynamics and pathogenesis in tripartite bromoviruses	11
Transmembrane redox regulation of genome replication functions in positive-strand RNA viruses	11
Editorial Board	11
Current view and perspectives in viroid replication	11
Host defence and persistent human papillomavirus infection	11
Broad neutralizing antibody-based strategies to tackle influenza	11
Cryo-electron tomography of viral infection — from applications to biosafety	11
Sending mixed signals: polyomavirus entry and trafficking	10
Innate immunity and HBV persistence	10
Hepatitis B virus e antigen and viral persistence	10
Immunotherapy and therapeutic vaccines for chronic HBV infection	10
Lying low-chromatin insulation in persistent DNA virus infection	10
The impact of high-resolution structural data on stemming the COVID-19 pandemic	10
Bat virome research: the past, the present and the future	10
Remdesivir for the treatment of Covid-19: the value of biochemical studies	10
Ribosomes in poxvirus infection	10
Structure and function of SARS-CoV-2 polymerase	9
HIV persistence: silence or resistance?	9
Endocytosis of Bacteriophages	9
Editorial Board	9
Editorial Board	9
Arms race between rice and viruses: a review of viral and host factors	9
Koala retrovirus and neoplasia: correlation and underlying mechanisms	9
Animal models of SARS-CoV-2 transmission	9
Editorial overview	9
The role of the animal host in the management of bacteriophage resistance during phage therapy	9
European regulatory aspects of phage therapy: magistral phage preparations	9
HIV-1 entry: Duels between Env and host antiviral transmembrane proteins on the surface of virus particles	9
The role of human lipoproteins for hepatitis C virus persistence	9
Editorial Board	9